Overall Status

Completed (2)

Enrolling by invitation (1)

Terminated (1)

Phase

n/a (1)

phase 3 (1)

phase 4 (1)

Sponsor

Chiesi Farmaceutici S.p.A. (1)

Melbourne Health (1)

The Cleveland Clinic (1)

University of California, San Diego (1)

Collaborator

Austin Hospital, Melbourne Australia (1)

National Cancer Institute (NCI) (1)

Peter MacCallum Cancer Centre, Australia (1)

University of California, Davis (1)

University of California, Irvine (1)

University of California, Los Angeles (1)

University of California, San Francisco (1)

Walter and Eliza Hall Institute of Medical Research (1)

Western Sydney Local Health District (1)

Intervention

5-fluorouracil (1)

advagraf® (1)

blood sampling (1)

envarsus® (1)

Study Documents

Intervention Type

drug (2)

diagnostic test (1)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (3)

Observational [Patient Registry] (1)

organ or tissue transplant; complications

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cytomegalovirus Infections, Haematological Malignancy, Organ or Tissue Transplant; Complications Trial in Parkville (Blood

Enrolling by invitation

Cytomegalovirus Infections
+3 more

Blood sampling

Parkville, Victoria, Australia

Royal Melbourne Hospital

Apr 28, 2022

Actinic Keratosis, Organ or Tissue Transplant; Complications Trial in Cleveland (5-Fluorouracil)

Terminated

Has Results

Actinic Keratosis
Organ or Tissue Transplant; Complications

5-Fluorouracil

Cleveland, Ohio

Cleveland Clinic

Mar 5, 2022

Organ or Tissue Transplant; Complications Trial in France (ENVARSUS®, ADVAGRAF®)

Completed

Organ or Tissue Transplant; Complications

Brest, France
+6 more

Jul 30, 2020

Diabetes, Cardiovascular Disease, Epilepsy Trial in United States

Completed

Diabetes
+10 more

Los Angeles, California
+4 more

Mar 13, 2018